REGLAN ODT Drug Patent Profile
✉ Email this page to a colleague
When do Reglan Odt patents expire, and what generic alternatives are available?
Reglan Odt is a drug marketed by Meda Pharms and is included in one NDA.
The generic ingredient in REGLAN ODT is metoclopramide hydrochloride. There are fourteen drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the metoclopramide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Reglan Odt
A generic version of REGLAN ODT was approved as metoclopramide hydrochloride by TEVA on July 29th, 1985.
Summary for REGLAN ODT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 89 |
Clinical Trials: | 34 |
Patent Applications: | 116 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for REGLAN ODT |
DailyMed Link: | REGLAN ODT at DailyMed |
Recent Clinical Trials for REGLAN ODT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mercy Health System | Phase 4 |
Women and Infants Hospital of Rhode Island | Phase 2 |
Emory University | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for REGLAN ODT
US Patents and Regulatory Information for REGLAN ODT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Meda Pharms | REGLAN ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021793-001 | Jun 10, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Meda Pharms | REGLAN ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021793-002 | Jun 10, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for REGLAN ODT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Meda Pharms | REGLAN ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021793-002 | Jun 10, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Meda Pharms | REGLAN ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021793-001 | Jun 10, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
Meda Pharms | REGLAN ODT | metoclopramide hydrochloride | TABLET, ORALLY DISINTEGRATING;ORAL | 021793-002 | Jun 10, 2005 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for REGLAN ODT
See the table below for patents covering REGLAN ODT around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2147669 | Formule de dosage robuste à dissolution rapide (Rapidly dissolving robust dosage form) | ⤷ Try a Trial |
Denmark | 2147669 | ⤷ Try a Trial | |
Spain | 2525720 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |